摘要

Objective: To investigate impact factors of TACE combined with radiofrequency ablation (RFA) for prognosis in patients with hepatocellular carcinoma (HCC). Methods: Clinic treatment and following data of 86 cases of HCC treated with TACE combined with RFA were analyzed retrospectively to observe treatment effect. Kaplan-Meier way was used to count the survival rate and generate the survival curve map. Cox regression analysis model was used to analyze 16 factors which may affect the prognosis. Results: The survival rates at 6, 12, 24, 36 months was 94.20, 89.40, 65.80 and 49.70, respectively, mean time was (42.98±3.80) months. Multivariable analysis revealed significant prognostic factors including liver function, Barcelona clinic cancer stage, tumor sizes and treatment effect. Conclusion: Liver function, Barcelona clinic cancer stage and tumor sizes are the risk prognostic factors, and treatment effect is a protective factor for HCC patients after TACE combined with RFA.